DMSO (dimethyl sulfoxide) reaches living tissue beneath the skin faster than most topical agents, and early clinical evidence suggests it can meaningfully reduce plantar fasciitis pain within days. A 2024 randomized trial found that roughly four out of five patients using a DMSO-based formulation on their heels reported an 85 percent or greater drop in pain scores after just ten days. But the story behind those numbers involves several distinct mechanisms and a few important caveats that anyone considering DMSO for heel pain should understand.
What Plantar Fasciitis Actually Is
The name “plantar fasciitis” implies inflammation, but tissue samples from people with the condition tell a different story. Histological findings show mainly chronic degenerative processes rather than active inflammation.1PubMed Central. Plantar Fasciitis: An Updated Review The plantar fascia itself is not a simple band of connective tissue. It consists of two distinct layers, a sheath and a core, each with different structural properties and different populations of stem cells. Researchers have proposed that plantar fasciitis results from abnormal mechanical responses of stem cells within these two layers, rather than from a straightforward inflammatory cascade.2PubMed Central. Characterization of the structure, cells, and cellular mechanobiological response of human plantar fascia
This distinction matters for evaluating any treatment. If the problem were purely inflammatory, a strong anti-inflammatory agent would be enough. Because the underlying issue is degeneration of collagen and dysfunctional tissue remodeling, an effective treatment likely needs to address pain, support tissue healing, or both. DMSO happens to have properties that touch on several of these fronts, which is why it has attracted interest despite the condition not being a textbook case of inflammation.
How DMSO Passes Through Skin
DMSO is a small, amphiphilic molecule, meaning it is comfortable in both water-loving and fat-loving environments. This dual nature is key to how it crosses the skin barrier. Your outermost skin layer, the stratum corneum, is essentially a wall of tightly packed lipid membranes. Most water-soluble drugs bounce off it; most fat-soluble drugs get stuck in it. DMSO does something unusual: it accumulates at the lipid-water boundary of cell membranes and begins disrupting their structure.3Biophysical Journal. Molecular Dynamics Simulation of Ceramide Bilayers in Water and Dimethylsulfoxide
Molecular simulations show that at moderate concentrations, DMSO replaces hydrogen bonds between the lipid molecules in these membranes with its own bonds, weakening the membrane’s structural network and making it more fluid. At higher concentrations, DMSO can actually induce temporary water pores through lipid bilayers, creating direct pathways for molecules to cross.4PubMed. Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes The practical result is striking speed: in porcine skin studies, DMSO was detectable in the epidermis within about four minutes of being applied to the surface, whereas glycerol took at least thirty minutes to reach the same depth.5PubMed. Penetration kinetics of dimethyl sulphoxide and glycerol in dynamic optical clearing of porcine skin tissue in vitro studied by Fourier transform infrared spectroscopic imaging
For plantar fasciitis, this penetration speed is relevant because the plantar fascia sits beneath a notoriously thick layer of skin on the sole of the foot. Topical treatments that work well on thinner skin elsewhere on the body often struggle to reach meaningful concentrations through the heel. DMSO’s ability to rapidly traverse and temporarily loosen that barrier gives it a practical advantage as both a stand-alone agent and as a vehicle for carrying other drugs along with it.
Two Separate Paths to Pain Relief
DMSO appears to relieve pain through at least two independent mechanisms, which is worth understanding because each operates on a different timescale.
The faster route is direct nerve blockade. When DMSO contacts peripheral nerves, it slows and eventually blocks conduction in C fibers, the small-diameter nerve fibers responsible for carrying dull, aching, and burning pain signals. Even at low concentrations of around 5 to 7 percent, C fiber conduction velocity drops measurably. At concentrations of about 9 percent and above, C fiber conduction can be blocked entirely, with higher concentrations producing near-immediate onset.6PubMed. Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesia If application continues, the block progressively extends from the smallest fibers to larger ones. Because small fibers handle noxious stimuli recognition, blocking them first aligns well with pain relief.7Experimental Neurology. Physiological effects of dimethyl sulfoxide on peripheral nerves: Possible role in pain relief This nerve-blocking effect likely accounts for the rapid relief some people feel after applying DMSO topically.
The slower route involves DMSO’s anti-inflammatory and free-radical-scavenging properties.8PubMed. Dimethyl sulfoxide prevents 7β-hydroxycholesterol-induced apoptosis by preserving lysosomes and mitochondria Even though plantar fasciitis is primarily degenerative, there is still a component of chemical irritation and localized inflammatory signaling in the affected tissue. DMSO scavenges hydroxyl radicals and selectively suppresses the production of interleukin-8 (IL-8), a signaling molecule that recruits immune cells to damaged tissue. In lab studies using human blood, a 1 percent DMSO solution blocked roughly 90 percent of IL-8 release without affecting cell viability or significantly reducing other inflammatory signals like tumor necrosis factor.9JCI Insight. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood This selective action is unusual. Most anti-inflammatory agents suppress a broad spectrum of inflammatory molecules. DMSO’s relatively targeted effect on IL-8, which is closely tied to reactive oxygen pathways, helps explain why it can reduce local tissue irritation without the systemic immune suppression that comes with oral anti-inflammatory drugs.
The Clinical Trial Evidence
As of mid-2025, there is one randomized, placebo-controlled trial directly studying DMSO-based treatment for plantar fasciitis. Published in 2024, the trial tested a formulation combining phytoterpenes (plant-derived compounds) dissolved in DMSO, applied topically to the heel. Patients in the active treatment group showed dramatic improvement: about 78 percent reported an 85 percent or greater decrease in total pain scores by day ten, using a validated foot function index. The placebo group showed no significant improvement. No adverse events were reported in either group.10PubMed Central. Randomized placebo controlled trial of phytoterpenes in DMSO for the treatment of plantar fasciitis
Those results are genuinely impressive, but a few things are worth keeping in mind. The study used DMSO as the vehicle for phytoterpenes, not DMSO alone. There was no arm testing DMSO by itself against placebo, so the trial cannot tell you how much of the effect came from DMSO and how much from the phytoterpenes it was carrying. It is plausible that DMSO contributed meaningfully through its own analgesic and anti-inflammatory actions while also ferrying the phytoterpenes deeper than they could reach on their own. But without a DMSO-only control arm, that remains an educated guess rather than proven fact.
The sample size was also relatively modest, with 32 patients in the active group. A single trial with a few dozen participants, however promising, is not the same as a large body of replicated evidence. For context, established plantar fasciitis treatments like shockwave therapy and corticosteroid injections rest on much larger evidence bases. The DMSO-phytoterpene approach is best described as promising early-stage evidence that warrants larger follow-up studies.
DMSO as a Drug Carrier for the Foot
Beyond its own therapeutic effects, DMSO’s most established role in medicine is as a penetration enhancer, helping other drugs get through the skin. It is considered a safe and effective mechanism for transdermal delivery of both water-soluble and fat-soluble medications.11PubMed. Dimethyl sulfoxide: an effective penetration enhancer for topical administration of NSAIDs This is particularly relevant for plantar fasciitis because oral anti-inflammatory drugs like ibuprofen or celecoxib have to travel through the entire bloodstream to reach the heel, and a meaningful dose may never arrive at the fascia. Topical delivery directly over the affected area sidesteps that problem, but only if the drug can actually get through the thick plantar skin.
Studies on celecoxib, a prescription anti-inflammatory, found that when combined with 5 or 10 percent DMSO, the drug achieved high permeation through skin. In animal models, this combination inhibited localized swelling nearly twice as effectively as a standard commercial formulation of the same drug.12PubMed. In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib The trade-off was that DMSO-enhanced formulations showed high permeation but relatively low skin retention, meaning the drug passed through quickly rather than lingering in the upper layers. For plantar fasciitis, where the target tissue lies beneath the skin, high permeation is arguably more useful than high retention.
This carrier function opens up a practical question for people considering DMSO: what you dissolve in it matters enormously. DMSO will carry nearly anything it dissolves through the skin barrier, which is a double-edged sword. If you apply DMSO to skin that has traces of household chemicals, lotions with questionable ingredients, or anything else you would not want in your bloodstream, DMSO can pull those along for the ride. Clean, dry skin is a prerequisite for safe application.
Side Effects and What to Expect
The most universal side effect of topical DMSO is the garlic or oyster-like odor on your breath. Your body metabolizes some of the DMSO into dimethyl sulfide, a volatile compound exhaled through your lungs. The smell can show up within minutes of skin application, which surprises people who did not expect a topical treatment to affect their breath. It fades as the body clears the metabolite, typically within a day or so.
Skin reactions are the most common local side effect. A systematic review of adverse reactions to DMSO found that dermatological reactions have a higher incidence when DMSO is administered through the skin, compared with other routes. These reactions typically include mild local burning or redness.13PubMed Central. Adverse reactions of dimethyl sulfoxide in humans: a systematic review Even in clinical settings where topical DMSO treatment continued for up to six weeks, the side effects were limited to mild local burning and the characteristic breath odor.14PubMed. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study More concerning reactions like cardiovascular or respiratory symptoms are associated primarily with intravenous DMSO administration, not topical use. The review concluded that adverse reactions to DMSO are generally mild, transient, and dose-related, meaning smaller doses carry lower risk.13PubMed Central. Adverse reactions of dimethyl sulfoxide in humans: a systematic review
One thing the safety literature does not fully address is long-term topical use on a specific body site like the heel. Most studies examine DMSO over weeks, not months. If you are using DMSO regularly for a chronic condition like plantar fasciitis, it is reasonable to monitor the application area for persistent skin changes and take breaks if irritation develops.
The Tendon Strength Concern
There is a biomechanical wrinkle that anyone using DMSO on or near tendons should know about. An older study on tendons found that topical DMSO application was associated with periods of decreased mean separation forces, essentially meaning the tendons became temporarily weaker. The researchers recommended avoiding vigorous muscular activity during DMSO therapy.15PubMed. Dimethyl sulfoxide. Biomechanical effects on tendons More recent work on connective tissue exposed to DMSO confirmed that higher concentrations can reduce tensile strength, likely by splitting the cross-links between collagen fibers.16Scientific Reports. The influence of different sample preparation on mechanical properties of human iliotibial tract
For plantar fasciitis, this is a genuine concern because the plantar fascia is a collagen-rich structure under constant mechanical load. If DMSO temporarily weakens collagen cross-linking in the fascia, jumping into a long run or an intense workout immediately after application could theoretically increase the risk of further tissue damage. The practical takeaway: apply DMSO during rest periods rather than right before activity. Evening application, when you are off your feet for the night, aligns better with both the pain-relief timeline and the precautionary biomechanical data.
Ultrasound-Assisted DMSO Delivery
Some physical therapy clinics use a technique called phonophoresis, where therapeutic ultrasound waves are used to drive topical agents deeper into tissue. Research on DMSO phonophoresis in traumatized muscle found that DMSO combined with pulsed ultrasound improved muscle healing and reduced markers of oxidative stress, including the production of damaging superoxide molecules. Interestingly, DMSO was effective at reducing the muscular lesion and oxidative stress only when used with the ultrasound, not on its own.17PubMed. Effects of therapeutic pulsed ultrasound and dimethylsulfoxide (DMSO) phonophoresis on parameters of oxidative stress in traumatized muscle
This suggests that for deeper structures like the plantar fascia, ultrasound-assisted delivery might push DMSO further than passive topical application alone. Ultrasound is already a common modality in physical therapy for plantar fasciitis, so combining it with DMSO gel rather than a standard coupling medium is a relatively low-risk modification. The research on this specific combination for plantar fasciitis has not been done yet, but the mechanistic rationale is solid.
Lessons from Equine Medicine
DMSO has a longer track record in veterinary medicine than in human practice, particularly for tendon injuries in horses. Equine tendinopathy shares some structural parallels with plantar fasciitis: both involve collagen-rich tissues under repetitive mechanical stress that develop degenerative changes. A comparative study in horses with tendinopathies found that animals treated with DMSO showed significant pain reduction and decreased lameness starting at three weeks and persisting through the six-week study period. Ultrasound imaging revealed improved fiber alignment in the DMSO group compared to animals treated with methylsulfonylmethane (MSM), a related sulfur compound sometimes marketed alongside DMSO.18Iraqi Journal of Veterinary Sciences. The role of DMSO and MSM in treatment of tendinopathies affection in equine: A comparative study
You cannot directly translate horse tendon results to human plantar fascia. The dosing, the tissue architecture, and the mechanical loads differ substantially. But the consistent pattern across species, where DMSO reduces pain and appears to support structural recovery in degenerated collagenous tissue, adds weight to the plausibility of its effects in humans. It also explains why DMSO remains a staple in equine sports medicine even as its human clinical evidence base is still catching up.
Practical Considerations for Topical Use
If you decide to try DMSO for plantar fasciitis, a few practical details are worth thinking through. Concentration matters: DMSO is available commercially in concentrations ranging from 50 to 99.9 percent. Higher concentrations penetrate faster and block nerve fibers more completely, but they also carry greater risk of skin irritation and temporary collagen-weakening effects. Many users and practitioners start around 50 to 70 percent and adjust based on tolerance. Pharmaceutical-grade DMSO is worth seeking out, since industrial-grade versions may contain impurities that DMSO will cheerfully transport through your skin.
Application technique is straightforward but demands cleanliness. Wash and thoroughly dry the heel and surrounding skin. Apply a thin layer with clean hands or a clean cotton pad. Avoid using latex gloves, which can dissolve in DMSO; nitrile gloves are the better choice if you prefer not to absorb DMSO through your fingers. The tingling or mild warmth you feel after application is normal and reflects the rapid skin penetration. The garlic-like breath odor is also expected and not a sign of overdose.
Timing is worth planning. Given the C fiber blocking effect and the possible temporary softening of collagen, applying DMSO before bed makes the most sense. You get the analgesic benefit during hours when you are not loading the fascia, and any transient weakening of collagen cross-links has time to resolve before you are back on your feet. Some people apply DMSO twice daily, but there is no clinical data establishing an optimal frequency specifically for plantar fasciitis. Starting with once-daily evening application and assessing your response over a week or two is a conservative approach.
DMSO is not FDA-approved for plantar fasciitis. Its only current FDA approval is for interstitial cystitis, a bladder condition treated with intravesical DMSO instillation. Topical DMSO for musculoskeletal pain exists in a gray zone: widely available, legal to purchase, supported by plausible mechanisms and limited clinical data, but without the regulatory stamp that comes from large-scale trials. Discussing it with a podiatrist or sports medicine physician, especially if you are also receiving corticosteroid injections or other treatments, helps avoid interactions and ensures your approach is coordinated.